Phu Thien Truong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Phu Thien Truong has a total of 105 co-authors. Here are the top co-authors by number of shared publications:
- Dung Lam-Quoc
Department of Pulmonary Medicine, Cho Ray Hospital, Ho Chi Minh City, Vietnam
2 shared publications - Van Thi Hue Tran
University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam
2 shared publications Anh Tuan Nguyen
Cho Ray Hospital, Ho Chi Minh City, Vietnam
1 shared publication- Anh-Thu Dau-Nguyen
Department of Pulmonary Medicine, Cho Ray Hospital, Ho Chi Minh City, Vietnam
1 shared publication - Binh Truong-Quang
Faculty of Medicine, University of Medicine and Pharmacy, Ho Chi Minh 700000, Vietnam
1 shared publication - Chinh Van Nguyen
University of Medicine and Pharmacy at Ho Chi Minh City 217 Hong Bang Ward 11 District 5 Ho Chi Minh City Vietnam
1 shared publication
Latest Publications
- 1 March 2026
- Published by Edizioni Internazionali srl, Divisione EDIMES Edizioni Medico-Scientifiche in Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
- Vol. 34 (1) , 57-70
Genomic epidemiology of Carbapenem-Resistant Enterobacterales in southern Vietnam: dominance of Klebsiella pneumoniae ST16 and horizontal gene transfer
Carbapenem-resistant Enterobacterales (CRE) pose a critical global threat. However, the genomic epidemiology, transmission dynamics (clonal vs. horizontal gene transfer), and mechanisms driving co-resistance in Southern Vietnam remain poorly understood. This study aimed to use Whole-Genome Sequencing (WGS) to characterize the molecular epidemiology, transmission mechanisms, and co-resistance patterns of CRE from a major referral center in Southern Vietnam We performed a cross-sectional study using whole-genome sequencing on 189 CRE isolates (K. pneumoniae, E. coli, E. cloacae) from a major referral hospital in Southern Vietnam. We analyzed Carbapenemase-Producing Genes (CPGs), MLST, colistin resistance mutations, plasmid clusters, and co-carried AMR genes. K. pneumoniae ST16 (n=67, 35.4%) was the most frequently identified clone, detected in 10/12 ward strata. We identified two distinct colistin resistance pathways linked to CPG lineage: blaKPC/blaOXA-48 family clones (ST147, ST5815, ST11) showed a universal prevalence of chromosomal pmrB mutations (n=55/55, 100%), whereas the blaNDM clone (ST16) exhibited a low frequency of these mutations (6.0%). Analysis of 10 plasmid clusters carrying CPGs revealed the frequent co-carriage of qnrS1 (quinolone resistance) and rmtB1 (amikacin resistance). CRE dissemination in Southern Vietnam is driven by a dual-transmission scenario. We identified distinct CPG-linked colistin resistance pathways and significant co-carriage of qnrS1 with CPGs. This highlights the potential risk of co-selection through antibiotic pressure. These findings underscore the urgent need for surveillance strategies targeting high-risk clones like K. pneumoniae ST16.
- 1 March 2026
- Published by Edizioni Internazionali srl, Divisione EDIMES Edizioni Medico-Scientifiche in Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
- Vol. 34 (1) , 57-70
Genomic epidemiology of Carbapenem-Resistant Enterobacterales in southern Vietnam: dominance of Klebsiella pneumoniae ST16 and horizontal gene transfer
Carbapenem-resistant Enterobacterales (CRE) pose a critical global threat. However, the genomic epidemiology, transmission dynamics (clonal vs. horizontal gene transfer), and mechanisms driving co-resistance in Southern Vietnam remain poorly understood. This study aimed to use Whole-Genome Sequencing (WGS) to characterize the molecular epidemiology, transmission mechanisms, and co-resistance patterns of CRE from a major referral center in Southern Vietnam We performed a cross-sectional study using whole-genome sequencing on 189 CRE isolates (K. pneumoniae, E. coli, E. cloacae) from a major referral hospital in Southern Vietnam. We analyzed Carbapenemase-Producing Genes (CPGs), MLST, colistin resistance mutations, plasmid clusters, and co-carried AMR genes. K. pneumoniae ST16 (n=67, 35.4%) was the most frequently identified clone, detected in 10/12 ward strata. We identified two distinct colistin resistance pathways linked to CPG lineage: blaKPC/blaOXA-48 family clones (ST147, ST5815, ST11) showed a universal prevalence of chromosomal pmrB mutations (n=55/55, 100%), whereas the blaNDM clone (ST16) exhibited a low frequency of these mutations (6.0%). Analysis of 10 plasmid clusters carrying CPGs revealed the frequent co-carriage of qnrS1 (quinolone resistance) and rmtB1 (amikacin resistance). CRE dissemination in Southern Vietnam is driven by a dual-transmission scenario. We identified distinct CPG-linked colistin resistance pathways and significant co-carriage of qnrS1 with CPGs. This highlights the potential risk of co-selection through antibiotic pressure. These findings underscore the urgent need for surveillance strategies targeting high-risk clones like K. pneumoniae ST16.
- Open Access
- 7 February 2026
- Published by Springer Nature in BMC Microbiology
- Vol. 26 (1)
First report of Candidozyma auris in Vietnam
Early diagnosis and treatment of Candidozyma auris improve survival. At Cho Ray Hospital, the organism was successfully identified using Vitek 2 and Vitek
- 7 February 2026
- Published by Springer Nature in BMC Microbiology
- Vol. 26 (1)
Open AccessFirst report of Candidozyma auris in Vietnam
Early diagnosis and treatment of Candidozyma auris improve survival. At Cho Ray Hospital, the organism was successfully identified using Vitek 2 and Vitek
- Open Access
- 2 January 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (1) , e45932
Emergence of Candida auris in Vietnam: A 3-year retrospective study from 2023 to 2025 at the Department of Pulmonary Medicine of Cho Ray Hospital
Candida auris is an emerging, multidrug-resistant fungal pathogen associated with severe infections, nosocomial outbreaks, and high mortality rates. Although its global prevalence is increasing, epidemiological and clinical data from Vietnam remain limited. This study provides the first characterization of C auris infections in Vietnam, highlighting clinical features, antifungal susceptibility, and outcomes to address a critical knowledge gap and inform local practice. A retrospective study was conducted at the Department of Pulmonary Medicine, Cho Ray Hospital, Vietnam, from January 2023 to July 2025. Adult patients (≥18 years) with confirmed C auris infection, identified from clinical specimens by MALDI-TOF MS, were included. Demographic, clinical, and microbiological data were extracted from medical records. Antifungal susceptibility was assessed using the ETEST method and interpreted according to the CDC breakpoints. Outcomes were defined as survival versus mortality at discharge. Statistical analyses were performed using STATA 15.1, with significance set at P < .05. Twenty-two patients were identified, with a median age of 67 years and 77.3% male. Most (81.8%) required intensive care, and all had underlying lung disease with pneumonia. The overall survival rate was 59.1%. Mortality was significantly associated with parenteral nutrition, malnutrition, hypoalbuminemia, and vasopressor use ( P < .05). Survivors more frequently exhibited co-isolation with non- auris Candida species ( P < .05). Antifungal susceptibility testing showed that most isolates remained sensitive, with fluconazole susceptibility observed in 86.4% of cases. This study represents the first report of C auris infections in Vietnam, demonstrating its clinical burden in patients with severe respiratory illness. Early detection, appropriate antifungal therapy, and nutritional optimization appear crucial for improving outcomes. Routine surveillance and larger multicenter studies are warranted to guide infection control and evidence-based management of C auris in resource-limited settings.
- 2 January 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (1) , e45932
Open AccessEmergence of Candida auris in Vietnam: A 3-year retrospective study from 2023 to 2025 at the Department of Pulmonary Medicine of Cho Ray Hospital
Candida auris is an emerging, multidrug-resistant fungal pathogen associated with severe infections, nosocomial outbreaks, and high mortality rates. Although its global prevalence is increasing, epidemiological and clinical data from Vietnam remain limited. This study provides the first characterization of C auris infections in Vietnam, highlighting clinical features, antifungal susceptibility, and outcomes to address a critical knowledge gap and inform local practice. A retrospective study was conducted at the Department of Pulmonary Medicine, Cho Ray Hospital, Vietnam, from January 2023 to July 2025. Adult patients (≥18 years) with confirmed C auris infection, identified from clinical specimens by MALDI-TOF MS, were included. Demographic, clinical, and microbiological data were extracted from medical records. Antifungal susceptibility was assessed using the ETEST method and interpreted according to the CDC breakpoints. Outcomes were defined as survival versus mortality at discharge. Statistical analyses were performed using STATA 15.1, with significance set at P < .05. Twenty-two patients were identified, with a median age of 67 years and 77.3% male. Most (81.8%) required intensive care, and all had underlying lung disease with pneumonia. The overall survival rate was 59.1%. Mortality was significantly associated with parenteral nutrition, malnutrition, hypoalbuminemia, and vasopressor use ( P < .05). Survivors more frequently exhibited co-isolation with non- auris Candida species ( P < .05). Antifungal susceptibility testing showed that most isolates remained sensitive, with fluconazole susceptibility observed in 86.4% of cases. This study represents the first report of C auris infections in Vietnam, demonstrating its clinical burden in patients with severe respiratory illness. Early detection, appropriate antifungal therapy, and nutritional optimization appear crucial for improving outcomes. Routine surveillance and larger multicenter studies are warranted to guide infection control and evidence-based management of C auris in resource-limited settings.
- Open Access
- 1 January 2026
- Published by Wiley in International Journal of Microbiology
- Vol. 2026 (1) , 5447477
Predominance of NDM and OXA‐48 Carbapenemase Coharboring Among Carbapenem Nonsusceptible Enterobacterales Isolates From Clinical Specimens at a Tertiary Hospital in Vietnam
Background: Antimicrobial resistance has emerged as a growing global public health threat. The increasing of carbapenem‐resistant Enterobacterales limits treatment options. A better understanding of the phenotype and genotype distribution of carbapenemase‐producing Enterobacterales is essential to prevent, reduce and control infection. This study is aimed at characterizing the phenotypic and genotypic carbapenemase profiles of carbapenem nonsusceptible Enterobacterales isolates collected from the diverse clinical specimens at a tertiary hospital in Ho Chi Minh City. Methods: A total of 619 carbapenem nonsusceptible Enterobacterales strains were isolated from 548 clinical specimens. Species identification and antimicrobial susceptibility testing were performed using the BD Phoenix M50 system. Carbapenemase production was assessed using the modified Carbapenem Inactivation Method (mCIM). Carbapenemase‐encoding genes, including bla KPC , bla NDM , bla IMP , bla OXA-23 , and bla OXA-48 , in isolates with positive or inconclusive mCIM results (559 of 619) were detected by multiplex RT‐PCR. Results: The results showed that median patient age was 71 years (IQR 60–81), with 55.7% of patient being male and 28.3% admitted to the intensive care unit. Klebsiella pneumoniae predominated (56.5%), followed by Klebsiella aerogenes (14.7%) and E. coli (14.4%). Resistance rates were 87.7% for ertapenem and 78.7% for meropenem. mCIM positivity was high in K. pneumoniae (92.9%), K. aerogenes (93.4%), and Serratia marcescens (92.7%), but lower in E. coli (59.6%) and E. cloacae (40.0%). All 9 carbapenemase‐gene‐positive isolates with inconclusive mCIM carried bla OXA-48 alone. In K. pneumoniae , bla NDM ‐ bla OXA-48 co‐carriage was most common (39.3%), followed by bla OXA-48 alone (26.2%), bla KPC alone (11.9%), and bla NDM alone (8.3%). E. coli and K. aerogenes predominantly harbored bla OXA-48 alone (66.7% and 58.1%). Conclusion: The findings show a high burden of carbapenem nonsusceptible Enterobacterales in a Vietnamese tertiary hospital, largely driven by K. pneumoniae coharboring bla NDM and bla OXA-48 . Continuous molecular surveillance and strengthened antimicrobial stewardship are urgently needed to limit their dissemination in Vietnam.
- 1 January 2026
- Published by Wiley in International Journal of Microbiology
- Vol. 2026 (1) , 5447477
Open AccessPredominance of NDM and OXA‐48 Carbapenemase Coharboring Among Carbapenem Nonsusceptible Enterobacterales Isolates From Clinical Specimens at a Tertiary Hospital in Vietnam
Background: Antimicrobial resistance has emerged as a growing global public health threat. The increasing of carbapenem‐resistant Enterobacterales limits treatment options. A better understanding of the phenotype and genotype distribution of carbapenemase‐producing Enterobacterales is essential to prevent, reduce and control infection. This study is aimed at characterizing the phenotypic and genotypic carbapenemase profiles of carbapenem nonsusceptible Enterobacterales isolates collected from the diverse clinical specimens at a tertiary hospital in Ho Chi Minh City. Methods: A total of 619 carbapenem nonsusceptible Enterobacterales strains were isolated from 548 clinical specimens. Species identification and antimicrobial susceptibility testing were performed using the BD Phoenix M50 system. Carbapenemase production was assessed using the modified Carbapenem Inactivation Method (mCIM). Carbapenemase‐encoding genes, including bla KPC , bla NDM , bla IMP , bla OXA-23 , and bla OXA-48 , in isolates with positive or inconclusive mCIM results (559 of 619) were detected by multiplex RT‐PCR. Results: The results showed that median patient age was 71 years (IQR 60–81), with 55.7% of patient being male and 28.3% admitted to the intensive care unit. Klebsiella pneumoniae predominated (56.5%), followed by Klebsiella aerogenes (14.7%) and E. coli (14.4%). Resistance rates were 87.7% for ertapenem and 78.7% for meropenem. mCIM positivity was high in K. pneumoniae (92.9%), K. aerogenes (93.4%), and Serratia marcescens (92.7%), but lower in E. coli (59.6%) and E. cloacae (40.0%). All 9 carbapenemase‐gene‐positive isolates with inconclusive mCIM carried bla OXA-48 alone. In K. pneumoniae , bla NDM ‐ bla OXA-48 co‐carriage was most common (39.3%), followed by bla OXA-48 alone (26.2%), bla KPC alone (11.9%), and bla NDM alone (8.3%). E. coli and K. aerogenes predominantly harbored bla OXA-48 alone (66.7% and 58.1%). Conclusion: The findings show a high burden of carbapenem nonsusceptible Enterobacterales in a Vietnamese tertiary hospital, largely driven by K. pneumoniae coharboring bla NDM and bla OXA-48 . Continuous molecular surveillance and strengthened antimicrobial stewardship are urgently needed to limit their dissemination in Vietnam.
- Open Access
- 31 December 2025
- Published by University of Medicine and Pharmacy at Ho Chi Minh City in MedPharmRes
- Vol. 9 (4) , 444-452
Molecular characterization and antimicrobial resistance of carbapenem-resistant Klebsiella pneumoniae and Escherichia coli at Cho Ray Hospital, Vietnam
Due to limited treatment options, the infection of carbapenem-resistant Enterobacterales (CRE), particularly Escherichia coli and Klebsiella pneumoniae, emerges as a critically imminent global health threat. This study aimed to investigate the prevalence and molecular characteristics of carbapenemase genes in CRE isolated from Cho Ray Hospital, and to assess their associated antimicrobial resistance profiles. A cross-sectional study was conducted on 160 non-duplicate CRE isolates collected from various clinical specimens at Cho Ray Hospital. Carbapenemase production was detected phenotypically using the modified carbapenem inactivation method and genotypically confirmed by multiplex real-time PCR targeting blaOXA, blaNDM, blaKPC, blaVIM, and blaIMP. K. pneumoniae accounted for 80.6% of isolates, while E. coli comprised 19.4%. The co-occurrence of blaOXA and blaNDM was the most common pattern (46.5% in K. pneumoniae). Notably, blaKPC was found in 17.8% of K. pneumoniae but not in E. coli. Colistin resistance was significantly higher in blaKPC isolates (30.4%) than blaNDM isolates (3.2%). The study highlights the high prevalence of dual carbapenemase gene carriage and the emergence of blaKPC at Cho Ray Hospital. These findings emphasize the importance of localized molecular surveillance and targeted infection control strategies in Vietnamese tertiary care settings.
- 31 December 2025
- Published by University of Medicine and Pharmacy at Ho Chi Minh City in MedPharmRes
- Vol. 9 (4) , 444-452
Open AccessMolecular characterization and antimicrobial resistance of carbapenem-resistant Klebsiella pneumoniae and Escherichia coli at Cho Ray Hospital, Vietnam
Due to limited treatment options, the infection of carbapenem-resistant Enterobacterales (CRE), particularly Escherichia coli and Klebsiella pneumoniae, emerges as a critically imminent global health threat. This study aimed to investigate the prevalence and molecular characteristics of carbapenemase genes in CRE isolated from Cho Ray Hospital, and to assess their associated antimicrobial resistance profiles. A cross-sectional study was conducted on 160 non-duplicate CRE isolates collected from various clinical specimens at Cho Ray Hospital. Carbapenemase production was detected phenotypically using the modified carbapenem inactivation method and genotypically confirmed by multiplex real-time PCR targeting blaOXA, blaNDM, blaKPC, blaVIM, and blaIMP. K. pneumoniae accounted for 80.6% of isolates, while E. coli comprised 19.4%. The co-occurrence of blaOXA and blaNDM was the most common pattern (46.5% in K. pneumoniae). Notably, blaKPC was found in 17.8% of K. pneumoniae but not in E. coli. Colistin resistance was significantly higher in blaKPC isolates (30.4%) than blaNDM isolates (3.2%). The study highlights the high prevalence of dual carbapenemase gene carriage and the emergence of blaKPC at Cho Ray Hospital. These findings emphasize the importance of localized molecular surveillance and targeted infection control strategies in Vietnamese tertiary care settings.
- 4 September 2025
- Published by Chiang Mai University in Journal of Associated Medical Sciences
- Vol. 58 (3) , 254-262
Performance of line probe assay and phenotypic drug susceptibility testing in detecting drug-resistant tuberculosis
Background: Tuberculosis (TB) still threatens human beings when drug-resistant tuberculosis (DR-TB), such as rifampicin-resistant TB, isoniazid-resistant TB, multidrug-resistant TB (MDR-TB), pre-extensively drug-resistant TB, and extensively drug-resistant TB increases continuously. The drug susceptibility testing (DST) is important to detect DR-TB for TB treatment. Objectives: The study aimed to assess first-line line probe assay (FL-LPA) performance of screening MDR-TB and detecting DR-TB on phenotypic drug susceptibility testing. Materials and methods: A laboratory-based study was performed at Cho Ray Hospital from August 2023 to August 2024. The sputum samples of presumptive TB were inoculated in Mycobacterium growth indicator tube (MGIT). Positive inoculum was examined in acid-fast bacilli (AFB) by Ziehl-Neelsen microscope. Cord-forming AFB were yielded to FL-LPA to identify Mycobacterium tuberculosis complex (MTBC); detect rifampicin-resistant TB, isoniazid-resistant TB, and MDR-TB. The identified MTBC was subjected to FL phenotypic DST (performed by BACTEC MGIT 960) with SIRE kit, considering gold standard to assess FL-LPA performance. The detected multidrug and/or rifampicin-resistant TB (MDR/RR-TB) were subjected to the second- line MGIT DST including ethionamide, amikacin, levofloxacin, and linezolid to screen pre-extensively drug-resistant TB and extensively drug-resistant TB. Results: Among 1853 samples inoculated, 621 positive MGIT tubes seen cord-forming AFB on Ziehl-Neelsen smear were performed to FL-LPA. Out of 621 LPA tests, 304 MTBC (61 isoniazid-resistant TB, 20 rifampicin-resistant TB, and 243 susceptible TB) were detected and compared to FL phenotypic DST. The excellent agreements between FL-LPA and FL phenotypic DST for detecting rifampicin-resistant TB, isoniazid- resistant TB, and MDR-TB were greater than 98%; kappa at 0.89 and above (p<0.001); with sensitivity values at 88.9% and above; specificity values at greater than 99%. For FL-MGIT DST, 101 (33.2%) were drug-resistant to at least one anti-TB agent, 81 (26.6%) to streptomycin, 60 (19.7%) to isoniazid, 20 (6.6%) to rifampicin. Among 20 MDR/RR-TB (2 rifampicin mono-resistant-TB and 18 MDR-TB) performed second line phenotypic DST, 25% resistance to ethionamide, and 100% susceptibility to amikacin, levofloxacin, and linezolid. Conclusion:The performance of FL-LPA to detect rifampicin-resistant TB, isoniazid- resistant TB, and MDR-TB agreed perfectly with phenotypic DST. The reaffirmed critical concentration of isoniazid, rifampicin and levofloxacin would be used to screen DR-TB on population.
- 4 September 2025
- Published by Chiang Mai University in Journal of Associated Medical Sciences
- Vol. 58 (3) , 254-262
Performance of line probe assay and phenotypic drug susceptibility testing in detecting drug-resistant tuberculosis
Background: Tuberculosis (TB) still threatens human beings when drug-resistant tuberculosis (DR-TB), such as rifampicin-resistant TB, isoniazid-resistant TB, multidrug-resistant TB (MDR-TB), pre-extensively drug-resistant TB, and extensively drug-resistant TB increases continuously. The drug susceptibility testing (DST) is important to detect DR-TB for TB treatment. Objectives: The study aimed to assess first-line line probe assay (FL-LPA) performance of screening MDR-TB and detecting DR-TB on phenotypic drug susceptibility testing. Materials and methods: A laboratory-based study was performed at Cho Ray Hospital from August 2023 to August 2024. The sputum samples of presumptive TB were inoculated in Mycobacterium growth indicator tube (MGIT). Positive inoculum was examined in acid-fast bacilli (AFB) by Ziehl-Neelsen microscope. Cord-forming AFB were yielded to FL-LPA to identify Mycobacterium tuberculosis complex (MTBC); detect rifampicin-resistant TB, isoniazid-resistant TB, and MDR-TB. The identified MTBC was subjected to FL phenotypic DST (performed by BACTEC MGIT 960) with SIRE kit, considering gold standard to assess FL-LPA performance. The detected multidrug and/or rifampicin-resistant TB (MDR/RR-TB) were subjected to the second- line MGIT DST including ethionamide, amikacin, levofloxacin, and linezolid to screen pre-extensively drug-resistant TB and extensively drug-resistant TB. Results: Among 1853 samples inoculated, 621 positive MGIT tubes seen cord-forming AFB on Ziehl-Neelsen smear were performed to FL-LPA. Out of 621 LPA tests, 304 MTBC (61 isoniazid-resistant TB, 20 rifampicin-resistant TB, and 243 susceptible TB) were detected and compared to FL phenotypic DST. The excellent agreements between FL-LPA and FL phenotypic DST for detecting rifampicin-resistant TB, isoniazid- resistant TB, and MDR-TB were greater than 98%; kappa at 0.89 and above (p<0.001); with sensitivity values at 88.9% and above; specificity values at greater than 99%. For FL-MGIT DST, 101 (33.2%) were drug-resistant to at least one anti-TB agent, 81 (26.6%) to streptomycin, 60 (19.7%) to isoniazid, 20 (6.6%) to rifampicin. Among 20 MDR/RR-TB (2 rifampicin mono-resistant-TB and 18 MDR-TB) performed second line phenotypic DST, 25% resistance to ethionamide, and 100% susceptibility to amikacin, levofloxacin, and linezolid. Conclusion:The performance of FL-LPA to detect rifampicin-resistant TB, isoniazid- resistant TB, and MDR-TB agreed perfectly with phenotypic DST. The reaffirmed critical concentration of isoniazid, rifampicin and levofloxacin would be used to screen DR-TB on population.
- Open Access
- 30 April 2024
- Published by Biomedpress in Biomedical Research and Therapy
- Vol. 11 (4) , 6333-6338
Detection of COVID-19 Patients through SARS-CoV-2 Antigen Assay using Chemiluminescence Immunoassay: Comparison to RT-PCR Method
Background: Accurate and reliable diagnostic tools are essential in effectively managing infectious diseases during the ongoing global COVID-19 pandemic. For this study, the RT-PCR assay was used as the reference method, and the objective was to determine the concordance rate, sensitivity, and specificity of the SARS-CoV-2 antigen assay (SARS-CoV-2 Ag) using the chemiluminescence immunoassay (CLEIA) technique for identifying COVID-19 patients. Method: A total of 231 nasopharyngeal swab samples were collected from individuals with either COVID-19 (cycle threshold (Ct) values ≤ 40) or non-COVID-19 (Ct values > 40 or undetected) diagnoses. These samples were examined using the SARS-CoV-2 Ag. Results: The overall concordance rate of the SARS-CoV-2 Ag was 84.0% (194/231), with a sensitivity of 81.4% (162/199) and 100% specificity (32/32). When samples were categorized into two Ct value groups, the SARS-CoV-2 Ag demonstrated a sensitivity of 97.6% for samples with a Ct value ≤ 30 and 2.9% for samples with a Ct value > 30. Moreover, the antigen concentration determined by the SARS-CoV-2 Ag showed a strong inverse correlation with the Ct value obtained from the RT-PCR assay (r = -0.93, p < 0.001). Conclusion: The SARS-CoV-2 Ag proves to be a potentially effective tool for diagnosing and monitoring COVID-19 patients, particularly in settings where the RT-PCR assay is not available.
- 30 April 2024
- Published by Biomedpress in Biomedical Research and Therapy
- Vol. 11 (4) , 6333-6338
Open AccessDetection of COVID-19 Patients through SARS-CoV-2 Antigen Assay using Chemiluminescence Immunoassay: Comparison to RT-PCR Method
Background: Accurate and reliable diagnostic tools are essential in effectively managing infectious diseases during the ongoing global COVID-19 pandemic. For this study, the RT-PCR assay was used as the reference method, and the objective was to determine the concordance rate, sensitivity, and specificity of the SARS-CoV-2 antigen assay (SARS-CoV-2 Ag) using the chemiluminescence immunoassay (CLEIA) technique for identifying COVID-19 patients. Method: A total of 231 nasopharyngeal swab samples were collected from individuals with either COVID-19 (cycle threshold (Ct) values ≤ 40) or non-COVID-19 (Ct values > 40 or undetected) diagnoses. These samples were examined using the SARS-CoV-2 Ag. Results: The overall concordance rate of the SARS-CoV-2 Ag was 84.0% (194/231), with a sensitivity of 81.4% (162/199) and 100% specificity (32/32). When samples were categorized into two Ct value groups, the SARS-CoV-2 Ag demonstrated a sensitivity of 97.6% for samples with a Ct value ≤ 30 and 2.9% for samples with a Ct value > 30. Moreover, the antigen concentration determined by the SARS-CoV-2 Ag showed a strong inverse correlation with the Ct value obtained from the RT-PCR assay (r = -0.93, p < 0.001). Conclusion: The SARS-CoV-2 Ag proves to be a potentially effective tool for diagnosing and monitoring COVID-19 patients, particularly in settings where the RT-PCR assay is not available.
- Open Access
- 3 April 2024
- Published by Microbiology Society in Microbiology
- Vol. 170 (3) , 001443
Adaptive response of Pseudomonas aeruginosa under serial ciprofloxacin exposure
Understanding the evolution of antibiotic resistance is important for combating drug-resistant bacteria. In this work, we investigated the adaptive response of Pseudomonas aeruginosa to ciprofloxacin. Ciprofloxacin-susceptible P. aeruginosa ATCC 9027, CIP-E1 (P. aeruginosa ATCC 9027 exposed to ciprofloxacin for 14 days) and CIP-E2 (CIP-E1 cultured in antibiotic-free broth for 10 days) were compared. Phenotypic responses including cell morphology, antibiotic susceptibility, and production of pyoverdine, pyocyanin and rhamnolipid were assessed. Proteomic responses were evaluated using comparative iTRAQ labelling LC-MS/MS to identify differentially expressed proteins (DEPs). Expression of associated genes coding for notable DEPs and their related regulatory genes were checked using quantitative reverse transcriptase PCR. CIP-E1 displayed a heterogeneous morphology, featuring both filamentous cells and cells with reduced length and width. By contrast, although filaments were not present, CIP-E2 still exhibited size reduction. Considering the MIC values, ciprofloxacin-exposed strains developed resistance to fluoroquinolone antibiotics but maintained susceptibility to other antibiotic classes, except for carbapenems. Pyoverdine and pyocyanin production showed insignificant decreases, whereas there was a significant decrease in rhamnolipid production. A total of 1039 proteins were identified, of which approximately 25 % were DEPs. In general, there were more downregulated proteins than upregulated proteins. Noted changes included decreased OprD and PilP, and increased MexEF-OprN, MvaT and Vfr, as well as proteins of ribosome machinery and metabolism clusters. Gene expression analysis confirmed the proteomic data and indicated the downregulation of rpoB and rpoS. In summary, the response to CIP involved approximately a quarter of the proteome, primarily associated with ribosome machinery and metabolic processes. Potential targets for bacterial interference encompassed outer membrane proteins and global regulators, such as MvaT.
- 3 April 2024
- Published by Microbiology Society in Microbiology
- Vol. 170 (3) , 001443
Open AccessAdaptive response of Pseudomonas aeruginosa under serial ciprofloxacin exposure
Understanding the evolution of antibiotic resistance is important for combating drug-resistant bacteria. In this work, we investigated the adaptive response of Pseudomonas aeruginosa to ciprofloxacin. Ciprofloxacin-susceptible P. aeruginosa ATCC 9027, CIP-E1 (P. aeruginosa ATCC 9027 exposed to ciprofloxacin for 14 days) and CIP-E2 (CIP-E1 cultured in antibiotic-free broth for 10 days) were compared. Phenotypic responses including cell morphology, antibiotic susceptibility, and production of pyoverdine, pyocyanin and rhamnolipid were assessed. Proteomic responses were evaluated using comparative iTRAQ labelling LC-MS/MS to identify differentially expressed proteins (DEPs). Expression of associated genes coding for notable DEPs and their related regulatory genes were checked using quantitative reverse transcriptase PCR. CIP-E1 displayed a heterogeneous morphology, featuring both filamentous cells and cells with reduced length and width. By contrast, although filaments were not present, CIP-E2 still exhibited size reduction. Considering the MIC values, ciprofloxacin-exposed strains developed resistance to fluoroquinolone antibiotics but maintained susceptibility to other antibiotic classes, except for carbapenems. Pyoverdine and pyocyanin production showed insignificant decreases, whereas there was a significant decrease in rhamnolipid production. A total of 1039 proteins were identified, of which approximately 25 % were DEPs. In general, there were more downregulated proteins than upregulated proteins. Noted changes included decreased OprD and PilP, and increased MexEF-OprN, MvaT and Vfr, as well as proteins of ribosome machinery and metabolism clusters. Gene expression analysis confirmed the proteomic data and indicated the downregulation of rpoB and rpoS. In summary, the response to CIP involved approximately a quarter of the proteome, primarily associated with ribosome machinery and metabolic processes. Potential targets for bacterial interference encompassed outer membrane proteins and global regulators, such as MvaT.
- Open Access
- 16 March 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (6) , 633
A Web-Based Dynamic Nomogram to Predict the Risk of Methicillin-Resistant Staphylococcal Infection in Patients with Pneumonia
The aim of this study was to create a dynamic web-based tool to predict the risks of methicillin-resistant Staphylococcus spp. (MRS) infection in patients with pneumonia. We conducted an observational study of patients with pneumonia at Cho Ray Hospital from March 2021 to March 2023. The Bayesian model averaging method and stepwise selection were applied to identify different sets of independent predictors. The final model was internally validated using the bootstrap method. We used receiver operator characteristic (ROC) curve, calibration, and decision curve analyses to assess the nomogram model’s predictive performance. Based on the American Thoracic Society, British Thoracic Society recommendations, and our data, we developed a model with significant risk factors, including tracheostomies or endotracheal tubes, skin infections, pleural effusions, and pneumatoceles, and used 0.3 as the optimal cut-off point. ROC curve analysis indicated an area under the curve of 0.7 (0.63–0.77) in the dataset and 0.71 (0.64–0.78) in 1000 bootstrap samples, with sensitivities of 92.39% and 91.11%, respectively. Calibration analysis demonstrated good agreement between the observed and predicted probability curves. When the threshold is above 0.3, we recommend empiric antibiotic therapy for MRS. The web-based dynamic interface also makes our model easier to use.
- 16 March 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (6) , 633
Open AccessA Web-Based Dynamic Nomogram to Predict the Risk of Methicillin-Resistant Staphylococcal Infection in Patients with Pneumonia
The aim of this study was to create a dynamic web-based tool to predict the risks of methicillin-resistant Staphylococcus spp. (MRS) infection in patients with pneumonia. We conducted an observational study of patients with pneumonia at Cho Ray Hospital from March 2021 to March 2023. The Bayesian model averaging method and stepwise selection were applied to identify different sets of independent predictors. The final model was internally validated using the bootstrap method. We used receiver operator characteristic (ROC) curve, calibration, and decision curve analyses to assess the nomogram model’s predictive performance. Based on the American Thoracic Society, British Thoracic Society recommendations, and our data, we developed a model with significant risk factors, including tracheostomies or endotracheal tubes, skin infections, pleural effusions, and pneumatoceles, and used 0.3 as the optimal cut-off point. ROC curve analysis indicated an area under the curve of 0.7 (0.63–0.77) in the dataset and 0.71 (0.64–0.78) in 1000 bootstrap samples, with sensitivities of 92.39% and 91.11%, respectively. Calibration analysis demonstrated good agreement between the observed and predicted probability curves. When the threshold is above 0.3, we recommend empiric antibiotic therapy for MRS. The web-based dynamic interface also makes our model easier to use.
- 29 August 2022
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 28 (12) , 1632-1638
Physical oral care prevents ventilator-associated pneumonia in Vietnam: A prospective interventional study
- 29 August 2022
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 28 (12) , 1632-1638
Physical oral care prevents ventilator-associated pneumonia in Vietnam: A prospective interventional study